<![CDATA[Pharmacists Can Help Shape the Future of GLP-1 Access]]>

No Clinician Interaction Needed for Many Online GLP-1 Receptor Agonist Prescribers

An online secret shopping study reveals easy access to GLP-1 prescriptions with limited clinician oversight

A Yale research team found that 92% of sites prescribed the GLP medication and 69% mailed it with little to no clinician oversight.

An online secret shopping study reveals easy access to GLP-1 prescriptions with limited clinician oversight

A Yale research team found that 92% of sites prescribed the GLP medication and 69% mailed it with little to no clinician oversight.

Phenome-wide analysis of downstream health outcomes following second-line antidiabetic agent prescriptions in All of Us

Explore the real-world impact: A study analyzed 17,267 T2D adults on GLP-1 RAs, revealing downstream health effects with electronic health r

Health tech companies rush to market 'GLP-1 ready' products as weight loss drug trend grows

In this week’s Optimizer, we take a look at how health tech companies are starting to incorporate features ‘built for GLP-1’ users.

Impact of GLP-1s on Life Insurance and Insights from a Health Tech Event

Patients look healthy on paper. Two years later, they're high-risk again.

It can take as little as 5 minutes online to get prescribed a GLP-1 for weight loss. Why that’s risky.

The research suggests that these companies prioritize “quick prescriptions” over good care